🇺🇸 Klaricid in United States

FDA authorised Klaricid on 25 August 2005

Marketing authorisations

FDA — authorised 25 August 2005

  • Application: ANDA065250
  • Marketing authorisation holder: ANI PHARMS
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA — authorised 31 May 2006

  • Application: ANDA065266
  • Marketing authorisation holder: WOCKHARDT
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 4 September 2007

  • Application: ANDA065283
  • Marketing authorisation holder: SANDOZ
  • Local brand name: CLARITHROMYCIN
  • Indication: FOR SUSPENSION — ORAL
  • Status: approved

Read official source →

FDA — authorised 15 September 2015

  • Application: ANDA202532
  • Marketing authorisation holder: LUPIN
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA — authorised 28 September 2015

  • Application: ANDA203584
  • Marketing authorisation holder: HEC PHARM
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 29 February 2016

  • Application: ANDA203243
  • Marketing authorisation holder: MPP PHARMA
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA — authorised 9 July 2018

  • Application: ANDA208987
  • Marketing authorisation holder: SUNSHINE
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA — authorised 25 April 2019

  • Application: ANDA206714
  • Marketing authorisation holder: JUBILANT CADISTA
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 31 January 2022

  • Application: ANDA210459
  • Marketing authorisation holder: ALEMBIC
  • Local brand name: CLARITHROMYCIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Other Other approved in United States

Frequently asked questions

Is Klaricid approved in United States?

Yes. FDA authorised it on 25 August 2005; FDA authorised it on 31 May 2006; FDA authorised it on 4 September 2007.

Who is the marketing authorisation holder for Klaricid in United States?

ANI PHARMS holds the US marketing authorisation.